DEF 14C

DEFINITIVE INFORMATION STATEMENT

Company: Inhibitor Therapeutics, Inc.
Filed: December 5, 2016
Period of Report: December 5, 2016
Accession Number: 0001193125-16-785159

View Document ↗ View on SEC.gov ↗